drugset / Trial / NCT05639777

Intranasal Dexmedetomidine in Children Undergoing Adenotonsillectomy Suffering From Mild Upper Respiratory Tract Infection

NCT05639777 ↗

Phase 4 Unknown 70 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to detect the efficacy of intranasal dexmedetomidine as a premedication to general anesthesia in pediatric patients with respiratory comorbidities undergoing adenotonsillectomy.

Timeline

Start
2022-12-06
Primary completion
2023-05-15
Completion
2023-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1.5 ug/kg Intranasal